Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Lake Bioscience CoSHSE:600866 -2.25%67 5-Year Yield-on-Cost % is 8.90 as of Aug. 19, 2026, which is 58% above its 10-year median of 5.63. GuruFocus rates SHSE:600866 with a GF Score™ of 67/100 and a GF Value™ of ¥5.90 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 149 Biotechnology companies, Star Lake Bioscience Co ranks better than 91.95% on this metric.
The historical rank and industry rank for Star Lake Bioscience Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:600866'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.63 Med: 5.63 Max: 8.96
Current: 8.9
During the past 13 years, Star Lake Bioscience Co's highest Yield on Cost was 8.96. The lowest was 4.63. And the median was 5.63.
SHSE:600866's 5-Year Yield-on-Cost % is ranked better than 91.95% of 149
companies
in the Biotechnology industry
Industry Median: 1.64
vs SHSE:600866: 8.90
Star Lake Bioscience Co (SHSE:600866) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Star Lake Bioscience Co 5-Year Yield-on-Cost % Related Terms
SHSE:600866 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Star Lake Bioscience Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's 5-Year Yield-on-Cost % falls into.
Star Lake Bioscience Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Star Lake Bioscience Co (SHSE:600866) has a 5-Year Yield-on-Cost % of 8.90 as of Aug. 19, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Star Lake Bioscience Co and its competitors. This is 58% above median its historical median of 5.63. Over the past decade, Star Lake Bioscience Co's 5-Year Yield-on-Cost % has ranged from 4.63 to 8.96. According to the industry distribution chart, Star Lake Bioscience Co ranks #12 out of 149 companies in the Biotechnology industry, placing it in the top 8.1%.
Is Star Lake Bioscience Co's 5-Year Yield-on-Cost % too high?
Star Lake Bioscience Co's current 5-Year Yield-on-Cost % of 8.90 is 58% above median its 10-year median of 5.63. Over the past 10 years, this metric has ranged from a low of 4.63 to a high of 8.96. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.64. Star Lake Bioscience Co's value of 8.90 is 442.7% above this industry median. Based on the distribution chart, Star Lake Bioscience Co ranks #12 out of 149 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Star Lake Bioscience Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Star Lake Bioscience Co ranks #12 out of 149 companies for 5-Year Yield-on-Cost %. This places Star Lake Bioscience Co in the top 8% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 1.64. Star Lake Bioscience Co's value of 8.90 is 442.7% above this benchmark. Historically, Star Lake Bioscience Co's own 5-Year Yield-on-Cost % has ranged from 4.63 to 8.96 over the past decade. While the company's 10-year median is 5.63 vs. the industry median of 1.64, Star Lake Bioscience Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.64, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Lake Bioscience Co's current 5-Year Yield-on-Cost % of 8.90 is 442.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Star Lake Bioscience Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Lake Bioscience Co's current 5-Year Yield-on-Cost % is 8.90, which is 58% above median its own 10-year median of 5.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.90, compared to a current price of ¥4.35 — trading 26.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 8.90, which is 58% above median its 10-year median of 5.63 and 442.7% above the Biotechnology industry median of 1.64. Star Lake Bioscience Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current 5-Year Yield-on-Cost % is 8.90 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?
Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued.
The current stock price of ¥4.35 is trading 26.3% below its estimated GF Value™ of ¥5.90.
GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.
Key valuation signals for SHSE:600866:
5-Year Yield-on-Cost %: 8.90 (58% above median its 10-year median of 5.63)
GF Value™: ¥5.90 vs. price of ¥4.35 (26.3% below fair value)
Industry Position: 442.7% above the Biotechnology median (#12 of 149)
No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
67GF Score
Get the complete analysis for SHSE:600866
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600866 has been successfully added to your 
